PRURISOL

Oral psoriasis drug candidate in a Phase 2b trial utilizing the advantages of 505(b)(2) development approach

KEVETRIN

Orphan-designated p53-modulating drug candidate in a Phase 2a trial for late-stage ovarian cancer  

BRILACIDIN

An immunomodulatory drug candidate with anti-inflammatory and antibiotic properties granted Fast Track status